Mounjaro vs Zepbound: what the labels say

Mounjaro and Zepbound contain the same active ingredient, tirzepatide, in the same six strengths. Both start at 2.5 mg once a week and go up in 2.5 mg steps to a maximum of 15 mg in adults.1, 2 What differs is what each is approved for. Mounjaro is for type 2 diabetes. Zepbound is for weight reduction and obstructive sleep apnea. This page reports the two labels. It does not tell you which to take.

Mounjaro and Zepbound side by side

ItemMounjaroZepbound
Active ingredientTirzepatide1Tirzepatide2
Approved forBlood sugar control in type 2 diabetes; lowering cardiovascular risk in adults with type 2 diabetes at high risk1Weight reduction in adults with obesity, or overweight with a weight-related condition; moderate to severe obstructive sleep apnea in adults with obesity2
AgesAdults, and ages 10 and older for blood sugar control1Adults2
Starting dose2.5 mg weekly12.5 mg weekly for 4 weeks, then 5 mg2
IncreasesBy 2.5 mg, after at least 4 weeks on a dose1By 2.5 mg, after at least 4 weeks on a dose2
Maintenance doses namedNone named in the dosing section15, 10 or 15 mg for weight reduction; 10 or 15 mg for sleep apnea2
Highest dose15 mg in adults; 10 mg for ages 10 and older115 mg2
FormsSingle-dose pen, single-dose vial, multi-dose vial, KwikPen1Single-dose pen, single-dose vial, multi-dose vial, KwikPen2
Missed doseTake within 4 days, otherwise skip1Take within 4 days, otherwise skip2

What each is approved for

Mounjaro

  • With diet and exercise, to improve blood sugar control in adults and pediatric patients aged 10 and older with type 2 diabetes.1
  • To lower the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk.1

Zepbound

  • To reduce excess body weight and keep it off in adults with obesity, or with overweight and at least one weight-related condition.2
  • To treat moderate to severe obstructive sleep apnea in adults with obesity.2

The Zepbound label says its safety and effectiveness have not been established in children.2

Is the dosing schedule different?

The wording differs slightly. The steps do not.

  • Mounjaro: start at 2.5 mg once a week, then increase in 2.5 mg steps after at least 4 weeks on the current dose.1
  • Zepbound: 2.5 mg once a week for 4 weeks, then 5 mg. After that, increases of 2.5 mg after at least 4 weeks on the current dose.2
The earliest timing either label allows, if the dose is raised at every step. Neither label says everyone increases. Our layout of the 4-week rule.
PeriodWeekly dose
Weeks 1 to 42.5 mg
Weeks 5 to 85 mg
Weeks 9 to 127.5 mg
Weeks 13 to 1610 mg
Weeks 17 to 2012.5 mg
Week 21 onward15 mg

Read side by side, neither brand is slower than the other. Both use 2.5 mg steps at least 4 weeks apart, so the earliest either reaches 15 mg is week 21. That timing is our arithmetic from the labels' rule.

Two real differences in the dosing sections:

  • The Zepbound label calls 2.5 mg a starting dose that is not for maintenance, and names maintenance doses: 5, 10 or 15 mg for weight reduction, and 10 or 15 mg for sleep apnea.2
  • The Mounjaro label sets a lower maximum, 10 mg a week, for pediatric patients.1

Full charts: Mounjaro, Zepbound, or both together.

Can one stand in for the other?

The ingredient and strengths are the same. The labels still treat them as separate products.

  • Neither label gives instructions for converting or switching between Mounjaro and Zepbound.1, 2
  • The Zepbound label does not recommend using it with other tirzepatide-containing products.2

Which one is prescribed depends on what it is being prescribed for. That is a decision for a prescriber.

Pens, vials and syringe units

Both brands come in the same four forms. Single-dose pens and vials hold one dose in 0.5 mL. Multi-dose vials and KwikPens hold 4 doses, each 0.6 mL.1, 2

On a U-100 insulin syringe, 1 mL equals 100 units.3 So by arithmetic, a dose from a single-dose vial is 50 units and a dose from a multi-dose vial is 60 units, whatever the strength. That applies to Lilly vials only. A compounded vial can have a different concentration. See the tirzepatide mg to units chart.

Missed doses and changing your day

The two labels give the same rules.1, 2

  • Take a missed dose as soon as possible within 4 days (96 hours).
  • If more than 4 days have passed, skip it and take the next dose on the regular day.
  • The weekly day can be changed as long as two doses are at least 3 days (72 hours) apart.

Storage

The storage rules are also the same.1, 2

  • Keep in the refrigerator at 2°C to 8°C (36°F to 46°F), in the original carton, away from heat and light. Do not freeze.
  • Single-dose pens and vials can be kept unrefrigerated, at up to 30°C (86°F), for a total of 21 days.
  • An opened multi-dose vial or KwikPen is discarded 30 days after first use, or after 4 weekly doses, even if medicine remains.

Warnings they share

Both labels carry a boxed warning about thyroid C-cell tumors, which tirzepatide causes in rats; whether it does so in humans is unknown.1, 2 Zepbound is contraindicated for people with a personal or family history of medullary thyroid carcinoma or with MEN 2, and for people with a known serious allergy to tirzepatide.2 The Mounjaro label lists the same contraindications.1

Nausea, diarrhea, vomiting, constipation and abdominal pain are among the most common side effects on both labels.1, 2 This is not the full safety information. Read the Medication Guide that comes with your prescription.

Questions

Are Mounjaro and Zepbound the same drug?

They contain the same active ingredient, tirzepatide, in the same strengths and the same pens and vials. They are approved for different uses.

Is Mounjaro dosing different from Zepbound dosing?

Both labels start at 2.5 mg once a week and increase in 2.5 mg steps after at least 4 weeks on a dose, up to 15 mg in adults. The Zepbound label also names maintenance doses.

Does Zepbound take longer to reach 15 mg than Mounjaro?

Not according to the labels. Both use 2.5 mg steps at least 4 weeks apart, so the earliest either reaches 15 mg is week 21. Not everyone goes to 15 mg.

Is Mounjaro approved for weight loss?

The Mounjaro label lists blood sugar control in type 2 diabetes and lowering cardiovascular risk in adults with type 2 diabetes. Weight reduction is on the Zepbound label.

Is Zepbound approved for diabetes?

The Zepbound label lists weight reduction and obstructive sleep apnea in adults with obesity. Blood sugar control in type 2 diabetes is on the Mounjaro label.

Can you take Mounjaro and Zepbound together?

The Zepbound label does not recommend using it with other tirzepatide-containing products.

Can children use Mounjaro or Zepbound?

Mounjaro is approved for blood sugar control in type 2 diabetes from age 10, with a maximum of 10 mg a week. The Zepbound label says safety and effectiveness have not been established in pediatric patients.

How many units is a dose from a Mounjaro or Zepbound vial?

By arithmetic, a single-dose vial holds each dose in 0.5 mL, which is 50 units on a U-100 syringe. A multi-dose vial gives each dose in 0.6 mL, which is 60 units.

Does this page tell me which one to take?

No. It reports what the two FDA labels say. Which medicine and dose suit you is a decision for your prescriber.

Sources

  1. Eli Lilly and Company. Mounjaro (tirzepatide) prescribing information, revised 8/2026. uspl.lilly.com/mounjaro (opens in a new tab)
  2. Eli Lilly and Company. Zepbound (tirzepatide) prescribing information and Instructions for Use, revised 8/2026. uspl.lilly.com/zepbound (opens in a new tab)
  3. Pennsylvania Patient Safety Authority, newsletter, June 2025: insulin syringes are marked in units, with 1 mL equal to 100 units. patientsafety.pa.gov (opens in a new tab)
  4. Formulas and test cases: how the calculator math works.